dpp4 vs sglt2 vs glp-1 Inhibitors Agonists | June 2021 | Clinical Corner GLP-1 receptor agonist versus DPP-4
Description
Feel lighter and more in control of your life
Learn what early research says about Orforglipron, a GLP-1 weight loss pill in trials
As part of its investor day on Thursday, Cigna's Evernorth arm announced an expansion to its GLP-1 management solution as well as the launch of a new behavioral-health-focused medical group
Beyond these established classes, novel agents such as dual and triple receptor agonists are currently being investigated
With GLP-1 weight loss comes muscle loss
10, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice
